Eikon Therapeutics Announces Availability of Six Abstracts for Presentation at the 2026 Annual Meeting of the American Society of Clinical Oncology

Presentations to cover progress across Eikon’s most advanced clinical-stage programsUpdated data will include those derived from trials of EIK1001...

Read on WOBR AI →